Financial Ratios

ORTIN LABORATORIES LTD.

NSE : ORTINLABBSE : 539287ISIN CODE : INE749B01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE19.480.17 (+0.88 %)
PREV CLOSE ( ) 19.31
OPEN PRICE ( ) 19.46
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1416
TODAY'S LOW / HIGH ( )19.35 19.48
52 WK LOW / HIGH ( )16.15 30.33
NSE19.550.2 (+1.03 %)
PREV CLOSE( ) 19.35
OPEN PRICE ( ) 19.95
BID PRICE (QTY) 19.55 (33)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6350
TODAY'S LOW / HIGH( ) 19.10 19.95
52 WK LOW / HIGH ( )16.2 30.35
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.12-0.491.16-0.330.76
   CEPS(Rs)0.19-0.131.510.821.79
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)13.3613.4713.9714.0614.81
   Tax Rate(%)15.2924.76-592.89178.4830.36
Margin Ratios
   Core EBITDA Margin(%)8.654.5615.252.883.72
   EBIT Margin(%)4.753.3512.371.993.01
   Pre Tax Margin(%)-1.84-6.441.670.361.10
   PAT Margin (%)-1.55-4.8411.58-0.290.76
   Cash Profit Margin (%)2.60-1.2715.070.701.81
Performance Ratios
   ROA(%)-0.45-1.901.37-0.511.43
   ROE(%)-0.86-3.575.38-2.315.21
   ROCE(%)1.661.563.278.9311.76
   Asset Turnover(x)0.290.390.121.781.88
   Sales/Fixed Asset(x)0.320.430.347.086.76
   Working Capital/Sales(x)-13.57-4.42-4.6422.9917.01
Efficiency Ratios
   Fixed Capital/Sales(x)3.142.312.960.140.15
   Receivable days201.69158.56917.6569.3364.92
   Inventory Days131.5579.221155.9580.3166.33
   Payable days125.6983.402833.92127.0086.88
Valuation Parameters
   PER(x)0.000.0027.740.0018.61
   PCE(x)90.35-175.1921.318.847.85
   Price/Book(x)1.301.682.310.520.95
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.382.914.040.150.25
   EV/Core EBITDA(x)36.1341.9825.474.996.04
   EV/EBIT(x)71.1186.6632.667.488.14
   EV/CE(x)0.961.161.550.250.39
   M Cap / Sales2.352.233.210.060.14
Growth Ratio
   Net Sales Growth(%)-26.860.78-95.8617.66110.46
   Core EBITDA Growth(%)-1.26-56.00-77.98-13.6016.33
   EBIT Growth(%)3.55-72.66-74.28-22.3221.32
   PAT Growth(%)76.52-142.17267.65-144.0688.46
   EPS Growth(%)76.52-142.17449.26-144.0688.46
Financial Stability Ratios
   Total Debt/Equity(x)0.590.560.610.820.78
   Current Ratio(x)0.940.760.781.101.14
   Quick Ratio(x)0.560.530.540.510.62
   Interest Cover(x)0.720.341.161.221.57
   Total Debt/Mcap(x)0.460.330.261.590.82

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.